GLPOneMedical is a clinician-reviewed reference on semaglutide, tirzepatide and the U.S. telehealth programs that prescribe them. We explain the trial evidence, dosing, safety and monitoring in plain English, and we publish dated, first-party price reads so you can compare programs. The site was first released on May 20, 2026 and is published by GLPOneMedical (Ranika Partners LLC, as named on the site).
What do we publish?
- Clinical reference pages on trials, dosing, side effects, contraindications and monitoring — see the clinical desk and guides.
- Evidence briefs and news on new data and regulation — see editorial and news.
- Provider reviews and a price index built from each seller's own pages, with the read date on every row.
Who researches and reviews our pages?
- Dr. Parmis — Medical Researcher, Western University of Health Sciences. Researches and writes our pages, reads the primary sources and keeps the data files current.
- Dr. Jonathan Snipes, MD — medical reviewer (NPI 1821250077).
- Kim Callender, NP (FNP-BC) — medical reviewer (NPI 1144661760).
Each page shows when it was released and when it was last reviewed, and the author block names who researched and reviewed it. You can check both NPI numbers in the public NPPES registry.
How is GLPOneMedical funded?
GLPOneMedical is affiliate-supported and may earn a commission when readers enroll through links on this site. Compensation never changes our methodology, rankings or the prices we report. Our current affiliate relationship is with NexLife, our editor's pick. We do not sell display ads or sponsored articles. NexLife ranks first under methodology v4.1 (94/100); other providers are listed alphabetically while they are re-scored. Read the methodology, the conflicts-of-interest page and the affiliate disclosure.
What changed on October 16, 2026?
Earlier versions of this page called GLPOneMedical "an independent editorial publication", named a four-physician advisory board that "sits independent of any provider we review", and said prices were checked "each week" by running checkout flows. We have replaced the reviewer panel, stopped describing the site as independent while it is affiliate-supported, and now record a dated first-party read for each price instead of claiming weekly checkouts. The full record is in the corrections log.
How do I contact the editors?
Journalists: see our press page.
Email glponemedical@gmail.com. For a correction, include the page URL, the claim and the source that shows it is wrong.